What does ZBIO invest in?

ProShares UltraPro Short Nasdaq Biotechnology is a equity fund issued by ProShares. ZBIO focuses on health care investments and follows the NASDAQ Biotechnology Index. The fund's investments total to approximately $2.85 million assets under management.

What is the management fee for ProShares UltraPro Short Nasdaq Biotechnology?

ProShares UltraPro Short Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 1.02%. However, ZBIO has a fee waiver of -0.82% to reimburse the expenses. The net expense ratio for ZBIO is 0.95%.

What other stocks do shareholders of ProShares UltraPro Short Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro Short Nasdaq Biotechnology investors own include ProShares UltraPro Short QQQ (SQQQ) , ProShares UltraPro QQQ (TQQQ) , Immunomedics (IMMU) , Direxion Daily S&P Biotech Bear 3x Shares (LABD) , Direxion Daily S&P Biotech Bull 3x Shares (LABU) , Direxion Daily Semiconductors Bull 3x Shares (SOXL) , Direxion Daily Small Cap Bull 3X Shares (TNA) , Direxion Daily Small Cap Bear 3X Shares (TZA) , Verizon Communications (VZ) and Eaton Vance Tax-Managed Buy-Write Opportunities Fund (ETV) .

NASDAQ:ZBIO

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO) Price, Holdings, & News

→ Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad)

Free ZBIO Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $10.09
▼
$10.09
50-Day Range: $10.02
▼
$10.09
52-Week Range: $8.28
▼
$18.64

Volume: N/A
Average Volume: 32,378 shs
Market Capitalization: $2.52 million

Assets Under Management: $2.85 million
Dividend Yield: 0.30%
Net Expense Ratio: 0.95%

Stock Analysis

About ProShares UltraPro Short Nasdaq Biotechnology

Ad Crypto Swap Profits

Claim Your Complimentary Bitcoin Reward

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

ZBIO ETF News Headlines

February 25, 2023 | benzinga.com

Bullfrog AI Hldgs Stock (NASDAQ:BFRG), Quotes and News Summary

February 16, 2023 | morningstar.com

ProFunds Short NASDAQ-100 Svc

September 17, 2022 | wsj.com

Nasdaq Biotechnology Index NBI

August 23, 2022 | ca.finance.yahoo.com

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO)

See More Headlines

Fund Details

Issuer: ProShares
Fund Name: ProShares UltraPro Short Nasdaq Biotechnology
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:ZBIO
Inception Date: 6/22/2015
Fund Manager: Michael Neches, Tarak Dave
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: NASDAQ Biotechnology Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 0

Fund Statistics

Assets Under Management: $2.85 million
Average Daily Volume: $25,501.70
Discount/Premium: 0.00%

Administrator, Advisor and Custodian

Administrator: J.P. Morgan Investor Services Co.
Advisor: ProShare Advisors LLC
Custodian: JPMorgan Chase Bank, N.A.
Distributor: SEI Investments Distribution Co.
Transfer Agent: JPMorgan Chase Bank, N.A.
Trustee: N/A
Lead Market Maker: Virtu Financial

Miscellaneous

Outstanding Shares: 250,000
Beta: N/A

Ad Crypto Swap Profits

Claim Your Complimentary Bitcoin Reward

Secure Your Spot Now

ProShares UltraPro Short Nasdaq Biotechnology Expenses

Type	ZBIO	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.75%	0.56%	0.54%	0.48%	0.51%
Other Expenses	1.02%	0.40%	0.54%	0.34%	0.58%
Total Expense	1.77%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	-0.82%	-0.53%	-0.55%	-0.22%	-0.56%
Net Expense	0.95%	0.60%	0.60%	0.54%	0.58%